135 related articles for article (PubMed ID: 27720203)
21. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
22. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
23. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
[TBL] [Abstract][Full Text] [Related]
24. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
26. External beam radiotherapy plus brachytherapy boost in treatment of anal canal carcinoma.
Stojanović S; Radosević-Jelić I; Dabić-Stanković K; Popov I; Josifovski J
Acta Chir Iugosl; 2007; 54(3):33-8. PubMed ID: 17988027
[TBL] [Abstract][Full Text] [Related]
27. Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.
Lestrade L; De Bari B; Pommier P; Montbarbon X; Lavergne E; Ardiet JM; Carrie C
Strahlenther Onkol; 2014 Jun; 190(6):546-54. PubMed ID: 24615188
[TBL] [Abstract][Full Text] [Related]
28. The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer - a benchmark for high-tech external beam radiotherapy alone?
Galalae RM; Zakikhany NH; Geiger F; Siebert FA; Bockelmann G; Schultze J; Kimmig B
Brachytherapy; 2014; 13(2):117-22. PubMed ID: 24360880
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.
Chapet O; Gerard JP; Riche B; Alessio A; Mornex F; Romestaing P
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1316-24. PubMed ID: 16169674
[TBL] [Abstract][Full Text] [Related]
30. High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study).
Hannoun-Levi JM; Ortholan C; Resbeut M; Teissier E; Ronchin P; Cowen D; Zaccariotto A; Bénézery K; François E; Salem N; Ellis S; Azria D; Gerard JP
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):712-20. PubMed ID: 20619552
[TBL] [Abstract][Full Text] [Related]
31. Patterns of failure and outcome in patients with carcinoma of the anal margin.
Khanfir K; Ozsahin M; Bieri S; Cavuto C; Mirimanoff RO; Zouhair A
Ann Surg Oncol; 2008 Apr; 15(4):1092-8. PubMed ID: 18231838
[TBL] [Abstract][Full Text] [Related]
32. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix.
Forrest JL; Ackerman I; Barbera L; Barnes EA; Davidson M; Kiss A; Thomas G
Int J Gynecol Cancer; 2010 Aug; 20(6):1074-8. PubMed ID: 20683420
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiotherapy with and without deep regional hyperthermia for squamous cell carcinoma of the anus.
Ott OJ; Schmidt M; Semrau S; Strnad V; Matzel KE; Schneider I; Raptis D; Uter W; Grützmann R; Fietkau R
Strahlenther Onkol; 2019 Jul; 195(7):607-614. PubMed ID: 30390114
[TBL] [Abstract][Full Text] [Related]
34. The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.
Smolska-Ciszewska B; Miszczyk L; Białas B; Fijałkowski M; Plewicki G; Gawkowska-Suwińska M; Giglok M; Behrendt K; Nowicka E; Zajusz A; Suwiński R
Radiat Oncol; 2015 Mar; 10():60. PubMed ID: 25884489
[TBL] [Abstract][Full Text] [Related]
35. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.
Rades D; Schwarz R; Todorovic M; Thurmann H; Graefen M; Walz J; Schild SE; Dunst J; Alberti W
Strahlenther Onkol; 2007 Jul; 183(7):398-402. PubMed ID: 17609874
[TBL] [Abstract][Full Text] [Related]
36. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
[TBL] [Abstract][Full Text] [Related]
37. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
El-Hadaad HA; Wahba HA; Roshdy S
J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
[TBL] [Abstract][Full Text] [Related]
38. [The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].
Valentini V; Mantello G; Luzi S; Genovesi D; Smaniotto D; Mantini G; Coco C; Ratto C; Sofo L; Cellini N
Radiol Med; 1997 Apr; 93(4):451-6. PubMed ID: 9244925
[TBL] [Abstract][Full Text] [Related]
39. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
40. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
